JT
JANX icon

Jupiter Topco’s Janux Therapeutics JANX Stock Holding History

Jupiter Topco’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.65M Buy
+172,229
New +$2.49M ﹤0.01% 1327

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco's JANX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Janux Therapeutics (JANX) in Q2 2026: 172,229 shares worth $2.65M. The stake represents ﹤0.01% of the portfolio and ranks #1327 among its holdings.

180 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Jupiter Topco held 172,229 shares of Janux Therapeutics worth $2.65M as of Q2 2026.
  • Janux Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Janux Therapeutics made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1327 holding.
  • 180 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.